Indefinite Delivery Contract 75N93021D00031

Active Awarded Last action

Contract number
75N93021D00031
Awardee
Awarding agency
Task orders
3 $1,055,908 obligated

Award facts

Opportunity
Combined order value
$1,055,908 Current and potential, with all options
Last date to order 74% complete
IDV ceiling <1% used
$545,452,906.00
Award type
Single award
Who can order
Only the awarding agency
Set-aside
No set-aside
Competition
Full and Open Competition · 29 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The National Institute of Allergy and Infectious Diseases awarded a single-award Indefinite Delivery contract valued at $545.5 million to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization headquartered in Albuquerque, New Mexico. The contract, effective September 1, 2021 through August 31, 2028, supports the Comprehensive and Rapid Response for NIAID Research Programs major program code and encompasses a broad spectrum of biomedical research services including clinical trials, nonclinical animal studies, manufacturing and controls, analytics, bioinformatics, computational biology, biostatistics, regulatory and quality assurance services, and basic mechanistic research. The solicitation specified that offerors must demonstrate expertise and qualified personnel capable of supporting NIAID's Division of Clinical Research, Division of Intramural Research, and Vaccine Research Center across designated NAICS codes 541715 and PSC codes R425. Although the original solicitation indicated a partial small business set-aside, the prime contract award itself was issued without set-aside designation.

To date, two delivery orders have been issued against this indefinite delivery vehicle: a $716,374 firm fixed price delivery order awarded September 26, 2022 for a Good Laboratory Practice repeat dose toxicology study of BPL-24910 with performance in Rockville, Maryland concluding December 1, 2023, and a $2,000 firm fixed price delivery order awarded September 1, 2021 for comprehensive and rapid response services with performance in Bethesda, Maryland concluding August 31, 2022. These task orders reflect the contract's intended purpose of providing flexible, rapidly deployable research support services that enable NIAID to address emerging infectious disease research needs and advance its broad research portfolio through established contractor relationships with demonstrated capability in preclinical research, safety evaluations, and infectious disease support services.

Task orders

Transactions

Action Obligated Date
Other Administrative Action P00003 $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 $0
Original award Comprehensive and rapid response for niaid research programs $0

Quick answers

Who was awarded contract 75N93021D00031?

75N93021D00031 was awarded to Lovelace Biomedical Research Institute by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2021.

How much is contract 75N93021D00031 worth?

Orders under 75N93021D00031 have obligated $1,055,908. 75N93021D00031's own ceiling is $545,452,906.

How many orders have been placed under contract 75N93021D00031?

3 orders have been placed under 75N93021D00031, the latest on September 28, 2026.

Who can order from contract 75N93021D00031?

75N93021D00031 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract 75N93021D00031 competed?

The extent of competition for 75N93021D00031 was full and open competition. The government received 29 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV